| Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization JH Paik, G Choe, H Kim, JY Choe, HJ Lee, CT Lee, JS Lee, S Jheon, ... Journal of Thoracic Oncology 6 (3), 466-472, 2011 | 333 | 2011 |
| Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma JH Paik, CM Choi, H Kim, SJ Jang, G Choe, DK Kim, HJ Kim, H Yoon, ... Lung cancer 76 (3), 403-409, 2012 | 203 | 2012 |
| Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of … H Kim, SB Yoo, JY Choe, JH Paik, X Xu, H Nitta, W Zhang, TM Grogan, ... Journal of Thoracic Oncology 6 (8), 1359-1366, 2011 | 186 | 2011 |
| High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions … PL Sun, H Seol, HJ Lee, SB Yoo, H Kim, X Xu, S Jheon, CT Lee, JS Lee, ... Journal of Thoracic Oncology 7 (2), 323-330, 2012 | 174 | 2012 |
| Artificial intelligence–powered spatial analysis of tumor-infiltrating lymphocytes as complementary biomarker for immune checkpoint inhibition in non–small-cell lung cancer S Park, CY Ock, H Kim, S Pereira, S Park, M Ma, S Choi, S Kim, S Shin, ... Journal of Clinical Oncology 40 (17), 1916-1928, 2022 | 154 | 2022 |
| Derivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learning Y Lee, JH Park, S Oh, K Shin, J Sun, M Jung, C Lee, H Kim, JH Chung, ... Nature Biomedical Engineering, 1-15, 2022 | 89 | 2022 |
| FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer AN Seo, Y Jin, HJ Lee, PL Sun, H Kim, S Jheon, K Kim, CT Lee, ... Virchows Archiv 465, 547-558, 2014 | 82 | 2014 |
| PD-L1 testing in non-small cell lung cancer: past, present, and future H Kim, JH Chung Journal of pathology and translational medicine 53 (4), 199, 2019 | 76 | 2019 |
| Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer YB Han, H Kim, M Mino-Kenudson, S Cho, HJ Kwon, KR Lee, S Kwon, ... Modern Pathology 34 (3), 549-561, 2021 | 74 | 2021 |
| A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations … H Kim, SJ Jang, DH Chung, SB Yoo, P Sun, Y Jin, KH Nam, JH Paik, ... PloS one 8 (10), e76999, 2013 | 74 | 2013 |
| High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas PL Sun, Y Jin, H Kim, CT Lee, S Jheon, JH Chung Cancer cytopathology 121 (6), 311-319, 2013 | 71 | 2013 |
| Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma H Ahn, JM Yang, H Kim, JH Chung, SH Ahn, WJ Jeong, JH Paik Oncotarget 8 (39), 66178, 2017 | 69 | 2017 |
| Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma E Park, SY Park, PL Sun, Y Jin, JE Kim, S Jheon, K Kim, CT Lee, H Kim, ... Oncotarget 7 (27), 42502, 2016 | 64 | 2016 |
| Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon … AN Seo, TI Park, Y Jin, PL Sun, H Kim, H Chang, JH Chung Lung Cancer 83 (3), 316-323, 2014 | 58 | 2014 |
| MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status H Kim, JM Yang, Y Jin, S Jheon, K Kim, CT Lee, JH Chung, JH Paik Oncotarget 8 (5), 8484, 2016 | 56 | 2016 |
| PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study H Kim, HJ Kwon, SY Park, E Park, JH Chung Oncotarget 8 (58), 98524, 2017 | 51 | 2017 |
| Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement H Kim, JH Chung Translational Lung Cancer Research 4 (2), 149, 2015 | 51 | 2015 |
| Alteration of the E-Cadherin/β-Catenin complex is an independent poor prognostic factor in lung adenocarcinoma H Kim, SB Yoo, P Sun, Y Jin, S Jheon, CT Lee, JH Chung Korean journal of pathology 47 (1), 44, 2013 | 51 | 2013 |
| Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients H Kim, HJ Kwon, YB Han, SY Park, ES Kim, SH Kim, YJ Kim, JS Lee, ... Modern Pathology 32 (3), 367-375, 2019 | 43 | 2019 |
| Discordance between anaplastic lymphoma kinase status in primary non‐small‐cell lung cancers and their corresponding metastases H Kim, X Xu, SB Yoo, PL Sun, Y Jin, JH Paik, G Choe, S Jheon, CT Lee, ... Histopathology 62 (2), 305-314, 2013 | 43 | 2013 |
